← Leaderboards
Toni I. Pollin
University Of Maryland Baltimore
$9,434,908
Attributed
$9,969,310
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,969,310 · 5
By mechanism
U01$4,259,612 · 1
R01$3,023,990 · 1
U24$1,858,618 · 2
P30$827,090 · 1
Top collaborators
- Alan R. Shuldiner2 shared
- Linda J.B. Jeng1 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Xiaoquan Rao$691,323
- Linda J.b. Jeng$138,769
Research focus
Non-Insulin-Dependent Diabetes MellitusBaseGeneticGenesDiabetes MellitusInsulinCardiovascular DiseasesUnited StatesMarylandHealth SystemProgramsUniversitiesFamily MemberEnd Stage Renal FailureEtiologyHyperglycemiaDiagnosisBlood Glucose RegulationAffectGenomicsComplexCessation Of LifeBlindnessAwareness
Grant awards (22)
Genomic Clinical Variant Expert Curation Panel for Monogenic Diabetes: A Gateway to Precision Medicine in Diabetes Mellitus$343,083
U24 · FY2025 · HD · contact PI
Genomic Clinical Variant Expert Curation Panel for Monogenic Diabetes: A Gateway to Precision Medicine in Diabetes Mellitus$343,083
U24 · FY2024 · HD · contact PI
Genomic Clinical Variant Expert Curation Panel for Monogenic Diabetes: A Gateway to Precision Medicine in Diabetes Mellitus$356,709
U24 · FY2023 · HD · contact PI
Genomic Clinical Variant Expert Curation Panel for Monogenic Diabetes: A Gateway to Precision Medicine in Diabetes Mellitus$265,738
U24 · FY2019 · HD · contact PI
Pilot and Feasibility$165,418
P30 · FY2019 · DK · contact PI
Genomic Diagnosis and Individualized Therapy of Highly Penetrant Genetic Diabetes$559,880
U01 · FY2018 · HG · contact PI
Genomic Clinical Variant Expert Curation Panel for Monogenic Diabetes: A Gateway to Precision Medicine in Diabetes Mellitus$272,468
U24 · FY2018 · HD · contact PI
Pilot and Feasibility$165,418
P30 · FY2018 · DK · contact PI
Genomic Diagnosis and Individualized Therapy of Highly Penetrant Genetic Diabetes$942,207
U01 · FY2017 · HG · contact PI
Genomic Clinical Variant Expert Curation Panel for Monogenic Diabetes: A Gateway to Precision Medicine in Diabetes Mellitus$277,537
U24 · FY2017 · HD · contact PI
Pilot and Feasibility$165,418
P30 · FY2017 · DK · contact PI
Genomic Diagnosis and Individualized Therapy of Highly Penetrant Genetic Diabetes$994,510
U01 · FY2016 · HG · contact PI
Pilot and Feasibility$165,418
P30 · FY2016 · DK · contact PI
Genomic Diagnosis and Individualized Therapy of Highly Penetrant Genetic Diabetes$971,748
U01 · FY2015 · HG · contact PI
The Metabolic Impact of Congenital Heterozygous ApoC-III Deficiency in Humans$585,844
R01 · FY2015 · HL · contact PI
Pilot and Feasibility$165,418
P30 · FY2015 · DK · contact PI
Genomic Diagnosis and Individualized Therapy of Highly Penetrant Genetic Diabetes (Administrative Supplment)$41,923
U01 · FY2015 · HG · contact PI
Genomic Diagnosis and Individualized Therapy of Highly Penetrant Genetic Diabetes$749,344
U01 · FY2014 · HG · contact PI
The Metabolic Impact of Congenital Heterozygous ApoC-III Deficiency in Humans$595,095
R01 · FY2014 · HL · contact PI
The Metabolic Impact of Congenital Heterozygous ApoC-III Deficiency in Humans$581,690
R01 · FY2013 · HL · contact PI
The Metabolic Impact of Congenital Heterozygous ApoC-III Deficiency in Humans$625,519
R01 · FY2012 · HL · contact PI
The Metabolic Impact of Congenital Heterozygous ApoC-III Deficiency in Humans$635,842
R01 · FY2011 · HL · contact PI